Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 10.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Intestine Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 189 100.0% 571 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 1 0.5% 4 0.7%
OKT3 3 1.6% 23 4.0%
Thymoglobulin 58 30.7% 97 17.0%
Zenapax 6 3.2% 80 14.0%
Simulect     12 2.1%
Campath 81 42.9% 65 11.4%
Rituximab 45 23.8% 7 1.2%
No Induction Drug Reported 44 23.3% 315 55.2%


Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader